je.st
news
Home
› Ensemble Therapeutics And Alexion Initiate Collaboration To Discover Macrocycle Drug Candidates Targeting Patients With Severe And Ultra-Rare Disorders
Ensemble Therapeutics And Alexion Initiate Collaboration To Discover Macrocycle Drug Candidates Targeting Patients With Severe And Ultra-Rare Disorders
2013-07-18 09:30:00| drugdiscoveryonline Home Page
Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the potential to modulate targets typically addressed by biologics, recently announced the initiation of a drug discovery collaboration with a subsidiary of Alexion Pharmaceuticals, Inc., the global biopharmaceutical company focused on developing and commercializing life-transforming therapies for patients with life-threatening, ultra-rare disorders
Tags: drug
discover
patients
collaboration
Category:Biotechnology and Pharmaceuticals